Oak Street Health
Oak Street Health raises $328M Series E at $3B valuation
Quick Facts
Oak Street Health: Series E Funding Round
Oak Street Health has successfully raised $328M in Series E funding, reaching a valuation of $3B.
Company Overview
Primary care for Medicare patients
Funding Details
The Series E round was led by General Atlantic, with participation from Newlight Partners.
Company Information
- Headquarters: Chicago, IL
- Founded: 2012
- Employees: 2500+
- Category: HealthTech
Investment
Oak Street Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- General Atlantic: Verified investor in Series E
- Newlight Partners: Verified investor in Series E
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
